Expression and secretion of endostatin in thyroid cancer

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3601-3608

  Hoffmann, Sebastian ^a   Wunderlich, Annette ^a   Lingelbach, Susanne ^a   Musholt, Petra B ^b   Musholt, Thomas J ^b   Von Wasielewski, Reinhard ^c   Zielke, Andreas ^d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Klinikum Offenbach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN; EPIDERMAL GROWTH FACTOR; THYROTROPIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PROTEIN EXPRESSION; PROTEIN SECRETION; THYROID CANCER; TISSUE MICROARRAY;

ADENOCARCINOMA, FOLLICULAR; ANGIOGENESIS INHIBITORS; CARCINOMA; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; PARAFFIN EMBEDDING; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; TUMOR CELLS, CULTURED;

EID: 58149299999     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0170-1     Document Type: Article

References (43)

1. J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 1182 6
2. J Folkmann 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4 6
3. R Kalluri 2003 Basement membranes: structure, assembly and role in tumor angiogenesis Nat Rev Cancer 3 422 33
4. D Hanahan J Folkmann 1996 Patterns and emerging mechanisms of the angiogenetic switch during tumorigenesis Cell 86 353 64
5. MS O'Reilly T Boehm Y Shing 1997 Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277 85
6. M Ferreras U Felbor T Lenhard 2000 Generation and degradation of human endostatin proteins by various proteinases FEBS Lett 486 247 51
7. RS Herbst KR Hess HT Tran 2002 Phase I study of recombinant human endostatin in patients with advanced solid tumors J Clin Oncol 20 3792 803
8. JP Eder Jr JG Supko JW Clark 2002 Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily J Clin Oncol 20 3772 84
9. J Folkman 2005 Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action Exp Cell Res 312 594 606
10. SA Wickstrom K Alitalo J Keski-Oja 2005 Endostatin signaling and regulation of endothelial cell-matrix interactions Adv Cancer Res 94 197 229
11. W Yang XY Li 2005 Anti- tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism Chin Med J 118 296 301
12. K Liby B Neltner L Mohamet 2003 Endostatin expression by MDA- MB- 435 breast cancer cells effectively inhibits tumor growth Cancer Biol Ther 2 53 4
13. E Kikuchi S Menendez M Ohori 2004 Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin Clin Cancer Res 10 1835 42
14. IV Subramanian R Gherbre S Ramakrishnan 2005 Adeno-associated virus-mediated delivery of mutant endostatin supresses ovarian carcinoma growth in mice Gene Ther 12 30 8
15. M Kirsch P Weigel T Pinzer 2005 Therapy of hematogenous melanoma brain metastasis with endostatin Clin Cancer Res 11 1259 67
16. S Tsuboi K Nouso Y Tomono 2004 Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by transplantes cells in nude mice Int J Oncol 25 1267 71
17. I Celik O Surucu C Dietz 2005 Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve Cancer Res 65 11044 50
18. RM Tjin Tham Sjin J Naspinski AE Birsner 2006 Endostatin therapy reveals a U-shaped curve for antitumor activity Cancer Gene Ther 13 619 27
19. NR Caron OH Clark 2004 Well differentiated thyroid cancer Scand J Surg 93 261 7
20. S Diehl CB Umbricht AP Dackiw 2005 Modern approaches to age-old questions about thyroid tumors Thyroid 15 575 82
21. KB Ain 1999 Anaplastic thyroid carcinoma: a therapeutic challenge Semin Surg Oncol 16 64 9
22. B McIver ID Hay DF Giuffrida 2001 Anaplastic thyroid carcinoma: a 50-year experience at a single institution Surgery 130 1028 34
23. JL Pasieka 2003 Anaplastic thyroid cancer Curr Opin Oncol 15 78 83
24. C Ye C Feng S Wang 2002 Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma Endocrinology 143 3522 8
25. S Hoffmann A Wunderlich I Celik 2006 Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy J Cell Biochem 98 954 65
26. Y Ishizaka F Itoh T Tahira 1989 Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line Jpn J Cancer Res 80 1149 53
27. T Hoelting A Zielke AE Siperstein 1994 Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro Clin Exp Metastasis 12 315 21
28. M Derwahl M Kuemmel PE Goretzki 1993 Expression of human TSH receptor in a human thyroid carcinoma cell line that lacks endogenous TSH receptor: growth inhibition by cAMP Biochem Biophys Res Commun 191 1131 7
29. A Zielke S Tezelman GH Jossart 1998 Establishment of a highly differentiated thyroid cancer cell line of Hürthle cell origin Thyroid 8 475 83
30. NE Heldin B Westermark 1991 The molecular biology of the human anaplastic thyroid carcinoma cell Thyroidology 3 127 31
31. M Mengel H Kreipe R von Wasielewski 2003 Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems Appl Immunohistochem Mol Morphol 11 261 8
32. C Langner M Ratschek P Rehak 2004 Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? J Clin Pathol 57 773 5
33. O Kisker CM Becker D Prox 2001 Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model Cancer Res 61 7669 74
34. UW Nilsson C Dabrosin 2006 Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo Cancer Res 66 4789 94
35. G Schuch O Kisker A Atala 2002 Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis Angiogenesis 5 181 90
36. AL Feldman HR Alexander SM Hewitt 2001 Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors J Natl Cancer Inst 93 1014 20
37. M Shaarawy SA El-Sharkawy 2001 Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer Acta Oncol 40 513 8
38. M Suzuki T Iizasa E Ko 2002 Serum endostatin correlates with progression and prognosis of non-small cell lung cancer Lung Cancer 35 29 34
39. AL Feldman HR Alexander Jr JC Yang 2002 Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma Cancer 95 1637 43
40. IS Woo KA Kim HM Jeon 2006 Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma Int J Cancer 119 2901 9
41. T Sasaki H Larsson J Kreuger 1999 Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin EMBO J 18 6240 8
42. TS Zorick Z Mustacchi SY Bando 2001 High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumors Eur J Hum Genet 9 811 4
43. S Korem MB Resnick Z Kraiem 1999 Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells J Clin Endocrinol Metab 84 3322 7